Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 3/2005

01-07-2005

Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer

Authors: Toshiyuki Kitai, Takuya Inomoto, Mitsuharu Miwa, Takahiro Shikayama

Published in: Breast Cancer | Issue 3/2005

Login to get access
Metadata
Title
Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer
Authors
Toshiyuki Kitai
Takuya Inomoto
Mitsuharu Miwa
Takahiro Shikayama
Publication date
01-07-2005
Publisher
Springer-Verlag
Published in
Breast Cancer / Issue 3/2005
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.2325/jbcs.12.211

Other articles of this Issue 3/2005

Breast Cancer 3/2005 Go to the issue

Report

Two cases with long-term disease-free survival after resection and radiotherapy for solitary brain metastasis from breast cancer with extensive nodal metastases

Report

Pathological complete response to trastuzumab and paclitaxel in a patient with inflammatory local recurrence following breast conserving surgery

OriginalPaper

The impact of bilateral breast cancer on the prognosis of breast cancer: a comparative study with unilateral breast cancer

OriginalPaper

Clinical and pathological features of glycogen-rich clear cell carcinoma of the breast

Report

Cryptogenic organizing pneumonia after radiotherapy for breast cancer

OriginalPaper

Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution following high dose chemotherapy in patients with breast cancer: results of a feasibility study in Japan
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits